Literature DB >> 12064476

Dopamine transport function is elevated in cocaine users.

Deborah C Mash1, John Pablo, Qinjie Ouyang, W Lee Hearn, Sari Izenwasser.   

Abstract

Dopaminergic transmission has been suggested to be a primary mechanism mediating reinforcement, withdrawal and craving associated with psychostimulant addiction. Pyscho-stimulants attenuate dopamine transporter (DAT) clearance efficiency, resulting in a net increase in synaptic dopamine levels. Re-uptake rate is determined by the number of functional DAT molecules at the membrane surface. Previous in vivo imaging studies in humans and in vitro studies in post-mortem human brain have demonstrated that chronic cocaine abuse results in a neuroadaptive increase in DAT-binding site density in the limbic striatum. Whether this increase in DAT availability represents an increase in the functional activity of the transporter is unknown. Here, we present evidence that DAT function is elevated by chronic cocaine abuse. The effect of increasing post-mortem interval on the functional viability of synaptosomes was modeled in the baboon brain. Baboon brains sampled under conditions similar to human brain autopsies yielded synaptosomal preparations that were viable up to 24 h post-mortem. Dopamine (DA) uptake was elevated twofold in the ventral striatum from cocaine users as compared to age-matched drug-free control subjects. The levels of [3H]DA uptake were not elevated in victims of excited cocaine delirium, who experienced paranoia and marked agitation prior to death. In keeping with the increase in DAT function, [3H]WIN 35,428 binding was increased in the cocaine users, but not in the victims of excited delirium. These results demonstrate that DA uptake function assayed in cryopreserved human brain synaptosomes is a suitable approach for testing hypotheses of the mechanisms underlying human brain disorders and for studying the actions of addictive drugs in man.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12064476     DOI: 10.1046/j.1471-4159.2002.00820.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  55 in total

1.  Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse.

Authors:  E Lehrmann; J Oyler; M P Vawter; T M Hyde; B Kolachana; J E Kleinman; M A Huestis; K G Becker; W J Freed
Journal:  Pharmacogenomics J       Date:  2003       Impact factor: 3.550

2.  Genetic variability of the extraneuronal monoamine transporter EMT (SLC22A3).

Authors:  Andreas Lazar; Dirk Gründemann; Reinhard Berkels; Dirk Taubert; Tim Zimmermann; Edgar Schömig
Journal:  J Hum Genet       Date:  2003-04-09       Impact factor: 3.172

3.  Dopaminergic marker proteins in the substantia nigra of human immunodeficiency virus type 1-infected brains.

Authors:  Janelle M Silvers; Michael Y Aksenov; Marina V Aksenova; Jacob Beckley; Petra Olton; Charles F Mactutus; Rosemarie M Booze
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

Review 4.  Trafficking of dopamine transporters in psychostimulant actions.

Authors:  Nancy R Zahniser; Alexander Sorkin
Journal:  Semin Cell Dev Biol       Date:  2009-01-22       Impact factor: 7.727

5.  Functional consequences of cocaine re-exposure after discontinuation of cocaine availability.

Authors:  Thomas J R Beveridge; Hilary R Smith; Susan H Nader; Michael A Nader; Linda J Porrino
Journal:  Neuropharmacology       Date:  2014-06-19       Impact factor: 5.250

6.  Mechanisms of acute cocaine toxicity.

Authors:  Kennon Heard; Robert Palmer; Nancy R Zahniser
Journal:  Open Pharmacol J       Date:  2008

7.  Molecular dynamics of conformation-specific dopamine transporter-inhibitor complexes.

Authors:  Bernandie Jean; Christopher K Surratt; Jeffry D Madura
Journal:  J Mol Graph Model       Date:  2017-07-11       Impact factor: 2.518

Review 8.  The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease.

Authors:  Phillip Mackie; Joe Lebowitz; Leila Saadatpour; Emily Nickoloff; Peter Gaskill; Habibeh Khoshbouei
Journal:  Brain Behav Immun       Date:  2018-03-15       Impact factor: 7.217

9.  Dopamine transporter levels in cocaine dependent subjects.

Authors:  Paul Crits-Christoph; Andrew Newberg; Nancy Wintering; Karl Ploessl; Mary Beth Connolly Gibbons; Sarah Ring-Kurtz; Robert Gallop; Julie Present
Journal:  Drug Alcohol Depend       Date:  2008-06-20       Impact factor: 4.492

Review 10.  2C or not 2C: phenethylamine designer drug review.

Authors:  Be Vang Dean; Samuel J Stellpflug; Aaron M Burnett; Kristin M Engebretsen
Journal:  J Med Toxicol       Date:  2013-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.